Coleen Glessner - 07 Apr 2023 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
EVP, Quality & Ethics, and CPL
Signature
/s/ Jennifer Lynne Fox, Attorney-in-fact
Issuer symbol
EBS
Transactions as of
07 Apr 2023
Net transactions value
$0
Form type
4
Filing time
10 Apr 2023, 19:41:42 UTC
Previous filing
06 Mar 2023
Next filing
13 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Tax liability $0 +480 +0.4% $0.000000 120,154 07 Apr 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld to pay taxes.